Animal model market
Animal Model Market, by Species Type (Rodents (Rats, Mouse, Guinea Pigs and Woodchuck), Rabbits, Monkeys, and Other Species), by Application (Toxicology Studies, Drug Discovery and Development, Basic and Applied Research, and Others), by End Users (Academic & Research Institutions, Contract Research Organizations (CROs), and Pharmaceutical companies), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028
- Jun 2022
- CMI2488
- 169 Pages
- Excel & Pdf
- Clinical Diagnostic
Animals are good research subjects for a variety of reasons. They are biologically similar to humans and susceptible to many of the same health problems. An animal model is a non-human species used in biomedical research because it can mimic aspects of a biological process or disease found in humans. It's a tool that researchers use to study diseases and test treatments in cases where human experimentation is not possible and/or unethical. Animal models generate hypotheses as to the developmental, molecular, cellular or physiological effects of a gene on human behavior. Mice and rats make up approximately 95% of all laboratory animals, with mice the most commonly used animal in biomedical research.
Market Statistics:
The global animal model market was valued at US$ 1,577.30 Mn in 2021 and is forecast to reach a value of US$ 2,394.30 Mn by 2028 at a CAGR of 6.0% between 2022 and 2028.
North America held dominant position in the global animal model market in 2022, accounting for 37.8% share in terms of volume, followed by Europe and Asia Pacific, respectively.
Figure 1. Global Animal Model Market Share (%), by Region, 2022
Recent Developments:
In October 2020, Taconic Biosciences announced the launch of its first hACE2 model. AC70 mouse experiences a lethal response to SARS-CoV-2 (COVID-19). The new AC22 mouse is lethality-resistant, enabling therapeutic, vaccine, and post-infection symptom research.
In March 2020, Crown Bioscience launched two new liver fibrosis rodent models, allowing more rapid and cost- effective evaluation of the preclinical effects of NASH and anti-fibrotic treatments on acute liver injury, advanced fibrosis, and/or fibrosis reversal.
Animal Model Market Report Coverage
Report Coverage | Details | ||
---|---|---|---|
Base Year: | 2021 | Market Size in 2021: | US$ 1,577.30 Mn |
Historical Data for: | 2017 to 2020 | Forecast Period: | 2022 to 2028 |
Forecast Period 2022 to 2028 CAGR: | 6.0% | 2028 Value Projection: | US$ 2,394.30 Mn |
Geographies covered: |
|
||
Segments covered: |
|
||
Companies covered: |
Charles River Laboratories International, Inc., The Jackson Laboratory, Taconic Biosciences, JSR Corporation (Crown Bioscience Inc.), Genoway S.A, Eurofins Scientific SE, Envigo, Perkinelmer, Inc. (Horizon Discovery Group), Ozgene Pty Ltd., and Hera Biolabs (Transposagen Biopharmaceuticals), among others. |
||
Growth Drivers: |
|
||
Restraints & Challenges: |
|
Market Drivers:
- Rise in usage of animal models in pre-clinical development by several research laboratories and biopharmaceutical industries is expected to augment the growth of the global animal model market during the forecast period. For example, in December 2021, World Health Organization (WHO) launched the SARS-CoV-2 Omicron variant assays and animal models study tracker, even as the highly mutant variant is spreading fast across the globe. WHO is already conducting research studies on variants of the SARS-CoV2 virus.
- Increasing implications of mouse clinical trials for more predictive outcomes is expected to boost the growth of the global animal model market during the forecast period. For example, in January 2020, Taconic Biosciences (Taconic Farms, Inc.), a global leader in providing drug discovery animal model solutions, expanded its premier immuno-oncology portfolio with the launch of the new B2m-NOG mouse model. Immuno-oncology leverages the body’s immune system to fight cancer, increasing the ability to target the disease.
Figure 2. Global Animal Model Market Share (%), by Animal Type, 2022
Market Restraints:
- Strict regulations and guidelines is expected to hamper growth of the global animal model market. For example, implementation of laws and regulations for animal protection and welfare has led to restrictive practices and restrictions on the use of animals for various purposes. Many countries worldwide have banned the usage of animal models.
- Growing opposition on animal testing by several organizations is expected to hinder growth of the global animal model market. There are many organizations worldwide that are against animal testing. Moreover, a Pew Research Center poll found that around 52% of U.S. adults oppose the use of animal models in scientific research.
Market Opportunities:
- The outbreak of COVID-19 is expected to offer significant growth opportunities for players in the global animal model market. For instance, in April 2021, Taconic Biosciences announced the launch of a new COVID-19 mouse model. This human ACE2 (hACE2) transgenic mouse expands Taconic’s COVID-19 research toolkit. hACE2 AC22 mouse provides a longer study window to assess drug efficacy compared to lethal infection models.
- Increasing number of research and development activities are expected to provide lucrative growth opportunities for players in the global animal model market. For instance, according to the WHO, between 1999 and 2021, the U.S. had the highest total number of trials (157,618), followed by China (80,333) and Japan (57,754). Moreover, in 2021, the U.S. and Germany led R&D (research and development) funding followed by a high-income country for COVID-19 vaccine related research activities.
Market Trends/Key Takeaways:
- Large number of applications in healthcare domain and physiological similarities between human and animal is expected to accelerate growth of the global animal model market during the forecast period. For example, in September 2020, Charles River's Research Models and Services division launched digital animal model ordering platform for North America. It is a giant step to reduce the risk of human error, improve operational communication, and give us better insight into how we can better serve the research community.
- Growing consumption of personalized medicine is expected to propel growth of the global animal model market over the forecast period. For example, the National Precision Medicine program and the Three Beyonds program were launched in Singapore for promoting the uptake of new technologies and digital infrastructure for supporting personalized healthcare.
Competitive Landscape:
Company Profiles:
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- ENVIGO
- EUROFINS SCIENTIFIC SE
- GENOWAY S.A.
- HERA BIOLABS (TRANSPOSAGEN BIOPHARMACEUTICALS)
- JSR CORPORATION (CROWN BIOSCIENCE INC.)
- OZGENE PTY LTD.
- PERKINELMER, INC. (HORIZON DISCOVERY GROUP PLC.)
- TACONIC BIOSCIENCES
- THE JACKSON LABORATORY
Table of Contents:
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Nasal Drug Delivery Mode, By Animal Type
- Market Nasal Drug Delivery Mode, By Application
- Market Nasal Drug Delivery Mode, By End Users
- Market Nasal Drug Delivery Mode, By Geography
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increase in usage of animal models
- Stringent rules and regulations
- Outbreak of COVID-19 (pandemic)
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- Market Dynamics
- Animal Model Market – Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
- Animal Model Market, By Animal Type, 2022-2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Rat
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Mice
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Guinea Pigs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Rabbits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Introduction
- Animal Model Market, Application, 2022-2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Drug Discovery & Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Basic Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Introduction
- Animal Model Market, By End User, 2022-2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Pharma & Biotech Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Academic Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Introduction
- Animal Model Market, By Geography, 2022-2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
- Middle East and Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
- Rest of World
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
- Introduction
- Competitive Landscape
- Charles River Laboratories International, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- The Jackson Laboratory
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Taconic Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- JSR Corporation (Crown Bioscience Inc.)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Genoway S.A
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eurofins Scientific SE
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Envigo
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Perkinelmer, Inc. (Horizon Discovery Group)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ozgene Pty Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hera Biolabs (Transposagen Biopharmaceuticals)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
- Charles River Laboratories International, Inc.
- Section
- Research Methodology
- About us
*Browse 24 market data tables and 28 figures on "Global Animal Model Market” - forecast to 2030
Detailed Segmentation:
- Global Animal Model Market, By Animal Type:
- Rat
- Mice
- Guinea Pigs
- Rabbits
- Others
- Global Animal Model Market, By Application:
- Drug Discovery & Development
- Basic Research and Others
- Global Animal Model Market, By End User:
- Pharma & Biotech Companies
- Academic Research Institutes
- Global Animal Model Market, By Region:
- North America
- Europe
- Asia-Pacific
- LAMEA